arrow
R

Reiko Horikawa

atlantic health system
H指数:45
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical practice guidelines for the management of differences of sex development in Japan

日本性发育异常的管理临床实践指南

2026-01-010
PRE
Clinical practice guidelines for the management of differences of sex development in Japan

日本性发育差异的管理临床实践指南

2025-12-010
PRE
JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease

JAK1 gain-of-function variant可导致斑秃、特应性皮炎和自身免疫性甲状腺疾病。

2025-10-140
PRE
Trends In Reported Outcomes for Growth Hormone Therapy In Children With Growth Hormone Deficiency

儿童生长激素缺乏症生长激素治疗报告结果的趋势

2025-09-010
OAAI
A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication

一项关于每日生长激素治疗全球超过80,000名生长障碍儿童的安全性与有效性的数据库研究:一项出版物的大众语言摘要

2025-08-170
OA
Efficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4

somapacitan每周给药治疗生长激素缺乏症患儿的疗效、安全性及胰岛素样生长因子I:REAL4研究3年结果

2025-05-220
OA
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society

关于生长激素缺乏症诊断的共识与争议:生长激素研究学会的德尔菲调查

2025-05-070
PRE
First-in-human clinical study of an embryonic stem cell product for urea cycle disorders

胚胎干细胞产品用于尿素循环障碍的首个人体临床试验

2025-03-060
OA
The Population-Attributable Fractions of Small-for-Gestational-Age Births: Results from the Japan Birth Cohort Consortium

小于胎龄儿的人口归因分数: 日本出生队列联盟的结果

2024-01-050
OAAI